10x Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TXG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Feb 26	SellUS$145,379	Benjamin Hindson	Individual	7,826	US$18.58
23 Feb 26	SellUS$166,593	Adam Taich	Individual	8,968	US$18.58
23 Feb 26	SellUS$178,928	Serge Saxonov	Individual	9,632	US$18.58
24 Nov 25	SellUS$157,363	Benjamin Hindson	Individual	8,283	US$19.00
24 Nov 25	SellUS$251,936	Serge Saxonov	Individual	13,261	US$19.00
24 Nov 25	SellUS$225,852	Adam Taich	Individual	11,888	US$19.00
22 Aug 25	SellUS$103,209	Benjamin Hindson	Individual	7,486	US$13.79
22 Aug 25	SellUS$307,657	Adam Taich	Individual	22,315	US$13.79
22 Aug 25	SellUS$128,881	Serge Saxonov	Individual	9,348	US$13.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TXG?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	9,927,453	7.52%
Institutions	122,058,718	92.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.57% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.7%	FMR LLC	18,633,198	US$624.2m	45.5%	0.02%
9.23%	ARK Investment Management LLC	11,717,317	US$392.5m	-7.5%	2.19%
7.94%	BlackRock, Inc.	10,079,244	US$337.7m	0.65%	no data
5.45%	Vanguard Portfolio Management, LLC	6,912,936	US$231.6m	0%	0.01%
4.26%	Quantinno Capital Management LP	5,411,761	US$181.3m	16%	0.24%
4.15%	Vanguard Capital Management, LLC	5,269,586	US$176.5m	0%	no data
4.03%	Amova Asset Management Co., Ltd.	5,110,214	US$171.2m	-6.95%	0.04%
3.28%	Serge Saxonov	4,158,355	US$139.3m	-0.12%	no data
2.43%	Benjamin Hindson	3,090,547	US$103.5m	-5.85%	no data
2.29%	Geode Capital Management, LLC	2,904,228	US$97.3m	4.1%	no data
2.24%	The Goldman Sachs Group, Inc.	2,838,803	US$95.1m	106%	0.02%
2.04%	State Street Global Advisors, Inc.	2,588,795	US$86.7m	3.04%	no data
1.95%	John Stuelpnagel	2,471,503	US$82.8m	0.88%	no data
1.91%	AQR Capital Management, LLC	2,419,446	US$81.1m	-1.23%	0.03%
1.8%	Jacobs Levy Equity Management Inc	2,283,424	US$76.5m	-13.5%	0.25%
1.79%	Casdin Capital, LLC	2,275,000	US$76.2m	62.5%	4.2%
1.63%	Millennium Management LLC	2,068,414	US$69.3m	66.5%	0.04%
1.61%	Dimensional Fund Advisors LP	2,042,950	US$68.4m	34.6%	0.01%
1.14%	Capital Research and Management Company	1,452,300	US$48.7m	0%	no data
1.14%	T. Rowe Price Group, Inc.	1,442,597	US$48.3m	3.2%	no data
1.11%	Eaton Vance Management	1,407,772	US$47.2m	-0.74%	0.01%
0.89%	Goldman Sachs Asset Management, L.P.	1,132,997	US$38.0m	-33.8%	0.01%
0.89%	Charles Schwab Investment Management, Inc.	1,127,056	US$37.8m	1.87%	no data
0.86%	Morgan Stanley	1,092,786	US$36.6m	-25.5%	no data
0.86%	Blue Water Life Science Advisors, LP	1,090,000	US$36.5m	0%	20.21%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/05 00:25
End of Day Share Price	2026/06/05 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

10x Genomics, Inc. is covered by 22 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Luke Sergott	Barclays
Michael Ryskin	BofA Global Research
Kyle Mikson	Canaccord Genuity